熱門資訊> 正文
Vericel预计2024年净收入在237至2.375亿美元之间
2025-01-15 05:27
- Vericel(VCEL) 0
- Melar Acquisition Corp. I Class A(MACI) 0
- Harbor AlphaEdge Small Cap Earners ETF(EBIT) 0
- Vericel Corporation (NASDAQ:VCEL) on Tuesday said its FY 2024 net revenue expected to be about $237 to $237.5 million, compared to consensus revenue estimates of $239.76 million.
- MACI net revenue expected to be approximately $197.2 to $197.7 million, representing 20% growth, said the company.
- Burn Care net revenue expected to be approximately $40 million, representing 22% growth.
- Gross margin expected to be approximately 72.5% in FY 2024.
- Non-GAAP adjusted EBITDA margin expected to be approximately 22% in FY 2024.
- As of December 31, 2024, the company had approximately $167 million in cash, restricted cash and investments, and no debt.
- Total Q4 preliminary net revenue expected to be approximately $75.2 million to $75.7 million.
- MACI Q4 net revenue expected to be approximately $68.2 to $68.7 million, representing 20% to 21% growth versus the prior year and approximately 53% growth versus the prior quarter.
- Burn Care Q4 net revenue expected to be approximately $7 million.
- Gross margin expected to be approximately 77% for Q4.
- GAAP net income expected to be approximately $17.5 to $18.5 million in Q4.
- Non-GAAP adjusted EBITDA margin expected to be approximately 39% in Q4.
- 2025 Financial Guidance:
- Total net revenue growth for 2025 expected to be 20% to 23%
- Gross margin expected to be 73% to 74%
- Adjusted EBITDA margin expected to be 25% to 26%
- Gross margin is expected to increase to the high-70% range by 2029.
- Adjusted EBITDA margin expected to increase to the high-30% range by 2029.
- VCEL -13.66% after hours to $50.69.
- Source: Press Release
More on Vericel
- Vericel Corporation: Hard To Justify Current Valuation
- Vericel GAAP EPS of -$0.02 beats by $0.03, revenue of $57.91M beats by $2.71M
- Seeking Alpha’s Quant Rating on Vericel
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
